[Towards evidence-based therapy in primary systemic vasculitis. Progress during the past decades have improved the situations of today's patients].
Segelmark
Mårten
M
Universitetssjukhuset i Lund marten.segelmark@skane.se
Westman
Kerstin
K
D019268:Antibodies, Antineutrophil Cytoplasmic / Q000032:analysis; D000964:Antimetabolites, Antineoplastic / Q000627:therapeutic use; D018906:Antineoplastic Agents, Alkylating / Q000627:therapeutic use; D001379:Azathioprine / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003520:Cyclophosphamide / Q000627:therapeutic use; D019317:Evidence-Based Medicine; D049673:History, 20th Century; D006801:Humans; D008727:Methotrexate / Q000627:therapeutic use; D015337:Multicenter Studies as Topic; D010956:Plasmapheresis; D012074:Remission Induction; D009626:Terminology as Topic; D014657:Vasculitis / Q000145:classification / Q000175:diagnosis / Q000188:drug therapy* / Q000266:history
D019268:Antibodies, Antineutrophil Cytoplasmic; D000964:Antimetabolites, Antineoplastic; D018906:Antineoplastic Agents, Alkylating; D003520:Cyclophosphamide; D001379:Azathioprine; D008727:Methotrexate